These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9543078)

  • 1. Intranasal fluticasone propionate reduces ICAM-1 on nasal epithelial cells both during early and late phase after allergen challenge.
    Ciprandi G; Ricca V; Passalacqua G; Fasolo A; Canonica GW
    Clin Exp Allergy; 1998 Mar; 28(3):293-9. PubMed ID: 9543078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
    Wang JH; Devalia JL; Rusznak C; Bagnall A; Sapsford RJ; Davies RJ
    Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis.
    Wang D; Duyck F; Smitz J; Clement P
    Allergy; 1998 Apr; 53(4):375-82. PubMed ID: 9574879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
    Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
    Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
    Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
    Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate: topical or systemic effects?
    Howland WC
    Clin Exp Allergy; 1996 May; 26 Suppl 3():18-22. PubMed ID: 8735854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study on fluticasone propionate aqueous nasal spray efficacy in patients with allergic rhinitis: evaluation of clinical and laboratory parameters.
    Ventura MT; Piccinni T; Matino MG; Giuliano G; Di Corato R; Di Napoli P; Tursi A
    Allergy; 2001 Jan; 56(1):29-34. PubMed ID: 11167349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity.
    Ciprandi G; Pronzato C; Passalacqua G; Ricca V; Grögen J; Mela GS; Varese P; Bertolini C; Bagnasco M; Canonica GW
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1088-96. PubMed ID: 8977510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge.
    Scadding GK; Darby YC; Austin CE
    Br J Clin Pharmacol; 1994 Nov; 38(5):447-51. PubMed ID: 7893587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
    Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
    Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis.
    Bronsky EA; Dockhorn RJ; Meltzer EO; Shapiro G; Boltansky H; LaForce C; Ransom J; Weiler JM; Blumenthal M; Weakley S; Wisniewski M; Field E; Rogenes P
    J Allergy Clin Immunol; 1996 Apr; 97(4):915-21. PubMed ID: 8655886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
    Baroody FM; Shenaq D; DeTineo M; Wang J; Naclerio RM
    J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
    Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
    J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate.
    Meltzer EO; Orgel HA; Rogenes PR; Field EA
    J Allergy Clin Immunol; 1994 Oct; 94(4):708-15. PubMed ID: 7930304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy.
    Ciprandi G; Pronzato C; Ricca V; Varese P; Del Giacco GS; Canonica GW
    Clin Exp Allergy; 1995 Sep; 25(9):871-8. PubMed ID: 8564726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
    Jen A; Baroody F; de Tineo M; Haney L; Blair C; Naclerio R
    J Allergy Clin Immunol; 2000 Apr; 105(4):732-8. PubMed ID: 10756223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.